Page last updated: 2024-09-03

elacridar and Acute Disease

elacridar has been researched along with Acute Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
den Ouden, D; Schoester, M; Sonneveld, P; van den Heuvel, M; van Rens, G1
Faussat, AM; Marie, JP; Simonin, G; Zhou, DC; Zittoun, R1

Other Studies

2 other study(ies) available for elacridar and Acute Disease

ArticleYear
In vitro effect of GF120918, a novel reversal agent of multidrug resistance, on acute leukemia and multiple myeloma cells.
    Leukemia, 1996, Volume: 10, Issue:12

    Topics: Acridines; Acute Disease; Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Resistance, Multiple; Humans; Isoquinolines; Kinetics; Leukemia, Myeloid; Multiple Myeloma; Neoplasm Proteins; Polymerase Chain Reaction; Rhodamine 123; Rhodamines; Tetrahydroisoquinolines; Transcription, Genetic; Tumor Cells, Cultured

1996
Effect of the multidrug inhibitor GG918 on drug sensitivity of human leukemic cells.
    Leukemia, 1997, Volume: 11, Issue:9

    Topics: Acridines; Acute Disease; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Membrane Permeability; Drug Resistance, Multiple; Gene Expression; Humans; Idarubicin; Isoquinolines; Leukemia; Mitoxantrone; RNA, Messenger; RNA, Neoplasm; Tetrahydroisoquinolines; Tumor Cells, Cultured; Verapamil

1997